相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liver transplantation around the world
James F. Trotter
CURRENT OPINION IN ORGAN TRANSPLANTATION (2017)
New insights after the first 1000 liver transplantations at The University of Hong Kong
See Ching Chan et al.
ASIAN JOURNAL OF SURGERY (2016)
Safety of mTOR inhibitors in adult solid organ transplantation
Pedro Ventura-Aguiar et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
Edward K. Geissler et al.
TRANSPLANTATION (2016)
Living donor liver transplantation for hepatocellular carcinoma at the University of Tokyo Hospital
Junichi Togashi et al.
HEPATOBILIARY SURGERY AND NUTRITION (2016)
OPTN/SRTR 2013 Annual Data Report: liver
W. R. Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience
Italo Bonadio et al.
CLINICAL TRANSPLANTATION (2015)
mTOR inhibitor therapy: Does it prevent HCC recurrence after liver transplantation?
Christophe Duvoux et al.
TRANSPLANTATION REVIEWS (2015)
Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation
M. Sterneck et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Liver transplantation: immunosuppression and oncology
Manuel Rodriguez-Peralvarez et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2014)
Mammalian target of rapamycin inhibitors are associated with lower rates of hepatocellular carcinoma recurrence after liver transplantation: a systematic review
Evangelos Cholongitas et al.
TRANSPLANT INTERNATIONAL (2014)
Living-Donor Liver Transplantation Associated With Higher Incidence of Hepatocellular Carcinoma Recurrence Than Deceased-Donor Liver Transplantation
Min-Su Park et al.
TRANSPLANTATION (2014)
SECTION 5. FURTHER EXPANDING THE CRITERIA FOR HCC IN LIVING DONOR LIVER TRANSPLANTATION: WHEN NOT TO TRANSPLANT: SNUH EXPERIENCE
Kwang-Woong Lee et al.
TRANSPLANTATION (2014)
Long-Term Outcome of Living Donor Liver Transplantation for Patients With Alcoholic Liver Disease
C. -S. Ahn et al.
TRANSPLANTATION PROCEEDINGS (2014)
Strategies for the management of adverse events associated with mTOR inhibitors
Bruce Kaplan et al.
TRANSPLANTATION REVIEWS (2014)
Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma
Nobuhisa Akamatsu et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Why does living donor liver transplantation flourish in Asia?
Chao-Long Chen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Liver Transplantation: East versus West
Akash Shukla et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2013)
Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
P. De Simone et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)
Rene Adam et al.
JOURNAL OF HEPATOLOGY (2012)
Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: A meta-analysis
Wenhua Liang et al.
LIVER TRANSPLANTATION (2012)
mTOR inhibitor-associated proteinuria in kidney transplant recipients
Fritz Diekmann et al.
TRANSPLANTATION REVIEWS (2012)
Mammalian Target of Rapamycin (mTOR) Inhibitors Potential Uses and a Review of Haematological Adverse Effects
Sofia Sofroniadou et al.
DRUG SAFETY (2011)
Everolimus Plus Reduced-Exposure CsA versus Mycophenolic Acid Plus Standard-Exposure CsA in Renal-Transplant Recipients
H. Tedesco Silva et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China
Jia Fan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Calcineurin inhibitor minimization protocols in liver transplantation
Stefan A. Farkas et al.
TRANSPLANT INTERNATIONAL (2009)
被撤回的出版物: Liver transplantation for hepatocellular carcinoma: Hangzhou experiences (Retracted article. See vol. 103, pg. 1736, 2019)
Shu-Sen Zheng et al.
TRANSPLANTATION (2008)
The Difference and the Transition of Indication for Adult Living Donor Liver Transplantation Between the West and the East
W. T. Bo et al.
TRANSPLANTATION PROCEEDINGS (2008)
Liver transplantation for hepatocellular carcinoma: Validation of the UCSF-Expanded criteria based on preoperative imaging
F. Y. Yao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Liver transplantation for hepatocellular carcinoma in Asia
Vanessa De Villa et al.
ONCOLOGIST (2007)
Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology
BJ Nankivell et al.
TRANSPLANTATION (2004)
Living-donor liver transplantation: 12 years of experience in Asia
CL Chen et al.
TRANSPLANTATION (2003)
分享论文
